drugset

drugset / Trial / NCT07029412

Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

NCT07029412 ↗

Phase 2 Completed 20 enrolled MBX Biosciences

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the preliminary efficacy of single SC administration of MBX 1416 at different dose levels in patients with PBH

Timeline

Start: 2025-08-26
Primary completion: 2026-04-18
Completion: 2026-05-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MBX 1416	Unknown	—	Subcutaneous

Indications